KL-6 is a marker of epithelial damage and has been studied as a biomarker for ILD diagnosis and prognosis, including a decline in lung functions and mortality, as well as response to treatment [13,14,15,16]. This evidence concerns the gene MUC1 and interstitial lung disease.